BSE filing, NSE: PNC. Summary written from the filing by ALFA Finder's alert engine.
Pritish Nandy Communications Ltd: key numbers
- Share price
- ₹17.81
- Market cap
- ₹25.77 Cr
- Revenue (annual)
- ₹37.66 Cr
- Net profit (annual)
- ₹-12.54 Cr
- P/E (TTM)
- -1.9×Sector 28.2×
- Promoter holding
- 59.72%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Pritish Nandy Communications Ltd
All →PNC Media and Entertainment Board Meeting Date
PNC Media will hold a board meeting on 2 November 2026 to approve unaudited results for the quarter and half-year ended September 2026. The agenda also proposes an independent director re-appointment and a postal ballot notice.
PNC Media and Entertainment Other Announcement
PNC Media and Entertainment Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
PNC Media and Entertainment Annual General Meeting
PNC Media and Entertainment Limited held its 33rd Annual General Meeting on September 28, 2026, transacting routine business including the adoption of financial statements.
PNC Media and Entertainment Business Update
PNC Media begins principal photography of season 2 of The Royals, its Netflix romantic comedy. The Season 1 hit reached Netflix's Global Top 10 Non-English Shows.
Pritish Nandy Communications Other Announcement
Pritish Nandy Communications Limited will change its name to PNC Media and Entertainment Limited effective September 17, 2026. This is a routine administrative renaming with no financial impact.
Pritish Nandy Communications Annual Report
PNC Media and Entertainment Limited has filed its 33rd Annual Report for the financial year 2025-26, pursuant to Regulation 34 of SEBI (LODR) Regulations.
Other board meeting date announcements
All →Premier Synthetics Board Meeting Date
Premier Synthetics announced its Board of Directors meeting scheduled for 14 November 2026 to consider unaudited Q2 and H1 results. No financial figures or decisions are reported in this advance notice.
HCP Plastene Bulkpack Board Meeting Date
HCP Plastene Bulkpack scheduled a board meeting for 06 November 2026. It will consider unaudited results for the quarter and half year ending 30 September 2026.
Ultracab (India) Board Meeting Date
Ultracab (India) Ltd intimated that its Board meeting is scheduled for 04-Nov-2026 to consider unaudited standalone financial results. No results or financial figures are disclosed in this advance notice.
Texmaco Infrastructure & Holdings Board Meeting Date
Texmaco has scheduled a Board meeting on November 5, 2026, to approve Q2 and H2 FY27 financial results. Trading window stays closed for insiders pending results declaration.
Astonea Labs Board Meeting Date
Astonea Labs intimated that its Board is scheduled on 14 Nov 2026 to consider unaudited half-year results. The trading window remains closed until 48 hours post-announcement.
AstraZeneca Pharma India Board Meeting Date
AstraZeneca Pharma India scheduled its board meeting for 5 Nov 2026 to approve Q2/H1 FY27 results. The trading window remains closed until 7 Nov 2026.